View all IQVIA events

China has become the world’s second-largest MedTech market—but it remains among the most challenging to navigate.

Evolving regulatory requirements, procurement reforms, shifting trade tariffs, and the growing influence of commercial insurance and innovation incentives all add layers of complexity. Succeeding in China requires not only a deep understanding of the market but also the agility to adapt quickly.

IQVIA MedTech convenes senior leaders from Atos Medical (Coloplast) and Medtronic to share first-hand experiences and actionable strategies for addressing challenges and unlocking opportunities in China’s fast-moving medical device landscape.

Related solutions

Contact Us